Interferon-alpha (IFN alpha) plays a crucial role in the antiproliferation
and immunoregulatory activity through the specific cell surface receptor, i
nterferon-alpha/beta receptor (IFN alpha/beta R). We examined the immunohis
tochemical expression of IFN alpha/beta R in 91 hepatocellular carcinoma (H
CC), HCV-related chronic hepatitis (n=38) and cirrhosis (n=53), dysplastic
nodules (n=5), and normal liver (n=9). The level of IFN alpha/beta R increa
sed in chronic hepatitis and cirrhosis compared with normal liver. All the
dysplastic nodules showed moderate or high expression. In HCCs, 26% (24/91)
of patients showed high IFN alpha/beta R expression while the remaining 38
% (35/91) showed moderate, and 35% (32/91) no or faint expression. Clinicop
athological survey demonstrated a significant correlation between IFN alpha
/beta R expression and differentiation of carcinoma (P=0.0008) although the
re was no correlation between IFN alpha/beta R expression in HCC and surviv
al or disease-free survival. Thus, IFN alpha/beta R was expressed not only
in chronic hepatitis or liver cirrhosis but in HCC and its expression was s
ignificantly correlated with tissue differentiation of carcinoma.